Penumbra, Inc. (PEN)
324.64
+0.45
(+0.14%)
USD |
NYSE |
May 07, 16:00
324.64
0.00 (0.00%)
Pre-Market: 20:00
Penumbra Research and Development Expense (Annual) : 69.43M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Abbott Laboratories | 2.889B |
| Insulet Corp. | 301.10M |
| Globus Medical, Inc. | 146.94M |
| Stryker Corp. | 1.567B |